Jennison Associates’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-71,240
| Closed | -$686K | – | 603 |
|
|
2023
Q3 | $686K | Buy |
+71,240
| New | +$686K | ﹤0.01% | 508 |
|
|
2022
Q3 | – | Sell |
-66,879
| Closed | -$771K | – | 633 |
|
|
2022
Q2 | $771K | Sell |
66,879
-67,397
| -50% | -$777K | ﹤0.01% | 544 |
|
|
2022
Q1 | $1.69M | Buy |
134,276
+8,949
| +7% | +$113K | ﹤0.01% | 508 |
|
|
2021
Q4 | $1.46M | Sell |
125,327
-51,330
| -29% | -$598K | ﹤0.01% | 568 |
|
|
2021
Q3 | $2.31M | Buy |
176,657
+61,034
| +53% | +$797K | ﹤0.01% | 523 |
|
|
2021
Q2 | $1.49M | Buy |
115,623
+9,341
| +9% | +$120K | ﹤0.01% | 586 |
|
|
2021
Q1 | $1.19M | Sell |
106,282
-4,572
| -4% | -$51.1K | ﹤0.01% | 596 |
|
|
2020
Q4 | $1.26M | Sell |
110,854
-80,748
| -42% | -$920K | ﹤0.01% | 554 |
|
|
2020
Q3 | $1.72M | Buy |
+191,602
| New | +$1.72M | ﹤0.01% | 497 |
|